CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.

Cancer Med · 2023 · PMC9972070 · PMID 36082960

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The level of serum CEACAM6 was higher in LUAD patients than in HC, and it showed an increasing trend from stage I to stage IV (Figure 3A ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.